Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy [Phase 3]
Phase 3 trial of olaparib in germline BRCA1/2 mutated pancreatic cancer after non-progression on platinum therapy has completed and results …
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery [EARLY_Phase 1]
An early-phase (Phase 1) trial assessed the combination of ascorbic acid with chemotherapy for locally advanced, unresectable, or recurrent …
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer [Phase 1, Phase 2]
Phase I/II study investigating LDE225 in combination with gemcitabine and nab-paclitaxel in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism [Phase 2]
A Phase 2 randomized open-label study comparing subcutaneous dalteparin to direct oral anticoagulants for cancer-associated venous thromboem…
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle [NA]
A completed clinical trial evaluating endoscopic ultrasound-guided fine needle biopsy using a novel fork needle for pancreatic cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients [Phase 4]
Phase 4 trial update on the efficacy and safety of paclitaxel liposome plus S-1 as first-line therapy for advanced pancreatic cancer.
-
FDA approval · 2019-12-27FDA Approved: LYNPARZA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for LYNPARZA (olaparib) from AstraZeneca Pharmaceuticals LP. The approval updates the product labeli…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Accelerated Recovery Pathway for Discharge After Surgery in Patients With Pancreatic Cancer [NA]
This clinical trial update reports that the study evaluating an accelerated recovery pathway for discharge after pancreatic cancer surgery h…
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 [Phase 1, Phase 2]
Phase 1/2 trial evaluating CART133 for relapsed/chemo-refractory advanced malignancies completed, across multiple cancers.
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial update for autologous CAR-T/TCR-T cell immunotherapy targeting multiple malignancies; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas [Phase 2]
Phase II trial evaluating preoperative chemo with radiation for borderline unresectable pancreatic adenocarcinoma; study terminated with res…
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating dendritic cell immunotherapy for pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Clinical Phase II Clinical Study Evaluating the Toxicity and Efficacy of mFOLFIRINOX Associated With SBRT (Stereotactic Radiotherapy) in Patients With Unresectable Locally Advanced Pancreatic Cancer [Phase 2]
Phase II clinical trial evaluating mFOLFIRINOX with SBRT for unresectable locally advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Cancer Associated Thrombosis and Isoquercetin (CATIQ) [Phase 2, Phase 3]
Phase 2/3 clinical trial update for Cancer Associated Thrombosis and Isoquercetin (CATIQ) completed with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen [Phase 2]
Phase 2 clinical trial update evaluating ApaIRIS (Apatinib, Irinotecan, and S-1) for metastatic pancreatic cancer after AG regimen.
-
FDA approval · 2019-11-05FDA Approved: ERLOTINIB — Original Application (Armas Pharmaceuticals Inc.)
The FDA approved Armas Pharmaceuticals' original application (ANDA211960) for erlotinib hydrochloride as a generic version of erlotinib, for…
-
FDA approval · 2019-11-05FDA Approved: ERLOTINIB — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' generic Erlotinib (ERLOTINIB) under an Original Application (ANDA), providing a generic option f…
-
CLINICAL_TRIALS trial_result · 2019-10-24Clinical Trial Update: Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel [Phase 2]
Phase 2 trial update evaluating quality of life in locally advanced or metastatic pancreatic cancer treated with gemcitabine and nab-paclita…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA) [Phase 2]
Phase 2 trial evaluating chemoradiation with adjuvant chemotherapy for pancreatic cancer completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial update evaluating the combination of chemotherapy and radiation therapy in locally advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: SEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive Jaundice [NA]
This clinical trial update reports a terminated study evaluating preoperative placement of biliary self-expanding metal stents to unblock th…
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer. [Phase 2]
A Phase 2 trial comparing Abraxane plus gemcitabine versus gemcitabine alone in locally advanced unresectable pancreatic cancer has complete…
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial of CAR T cell therapy targeting mesothelin in metastatic cancer shows terminated status with posted results.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab [Phase 2]
Phase 2 trial assessing GVAX Pancreas Vaccine (with Cyclophosphamide) and CRS-207 with or without nivolumab in previously treated metastatic…
-
FDA approval · 2019-10-03FDA Approved: GEMCITABINE HYDROCHLORIDE — Supplemental Application (Gland Pharma Limited)
The FDA approved a supplemental application for gemcitabine hydrochloride from Gland Pharma Limited. This approval enables the marketing of …